Mahesh Karande serves as Executive at Omega Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mahesh Karande has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 1, 2022 involved exercising options for 11,300 shares valued at $6.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 1, 2022 | OMGA | $6.0K | Option Exercise | 11,300 | $0.53 | Discretionary |
Mahesh Karande currently holds 117,711 shares of Omega Therapeutics, Inc. (OMGA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mahesh Karande has been a net neutral trader of OMGA stock. They have purchased $0 and sold $0 worth of shares.
Mahesh Karande's most recent insider trade was on Feb 1, 2022, when they sold 11,300 shares at $0.53 per share.
Get notified when new Form 4 filings are submitted